IL6 and dermatitis: For instance, a study by Wrześniewska et al. found that SCFAs can reduce skin inflammation and enhance skin barrier function by promoting regulatory T cell (Treg) activity and suppressing pro-inflammatory cytokines such as IL-6 and TNF-α.